| Source HCPCS Code |
|
Target NDC Code |
Q5124
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
|
⇄
|
64406-0019-01
BYOOVIZ 0.5 MG/0.05 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.05 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IO |
| Billing Units |
ML |
|
|
|
Q5124
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
|
⇄
|
64406-0019-07
BYOOVIZ 0.5 MG/0.05 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.05 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IO |
| Billing Units |
ML |
|
|
|
Q5124
Inj. byooviz, 0.1 mg
|
⇄
|
64406-0019-01
Byooviz
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|